Hemodyn

Founded by an established bioengineer and a pediatric cardiovascular surgeon/inventor, Hemodyn aims to develop biomedical technology (software and devices) for children with heart diseases. Since its foundation Hemodyn raised over 250K Euro seed funding including a European Research Council PoC Proof of Concept grant.  Product line includes patented powerless pediatric asset devices and heart valves already tested in patients. Hemodyn also provides blood flow design platforms for cardiovascular surgeons tested in patients. These interactive tools allow surgeons to predict the outcome of their intended operations prior to the actual surgery. Multiple alternative surgical configurations aid decision-making leading patient specific optimization of the vital post-operative performance parameters.